Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT

Malladi, Srinivas, Macalinao, Danilo G., Jin, Xin, He, Lan, Basnet, Harihar, Zou, Yilong, de Stanchina, Elisa, Massagué, Joan·2016·Cell
DOI 10.1016/j.cell.2016.02.025

Cited by (790)

Items 501–600 of 790

  1. Dickkopf1: An Immunomodulator in Tissue Injury, Inflammation, and Repair
    Min Hee Park, Eun‐Ah Sung, Margot Sell, Wook‐Jin Chae · 2021 · ImmunoHorizons
  2. Fate decisions of breast cancer stem cells in cancer progression
    Hui Xu, Fengxia Zhang, Xiaokang Gao, Qiwang Zhou, Linhai Zhu · 2022 · Frontiers in Oncology
  3. Nestin-GFP transgene labels immunoprivileged bone marrow mesenchymal stem cells in the model of ectopic foci formation
    Dmitriy Vladimirovich Karpenko, Капранов Николай Михайлович, Alexey Bigildeev · 2022 · Frontiers in Cell and Developmental Biology
  4. Neutrophil Extracellular Traps in Tumors and Potential Use of Traditional Herbal Medicine Formulations for Its Regulation
    Xiang Li, Lei Hu, Abid Naeem, Shanghua Xiao, Ming Yang, Hongming Shang, Jing Zhang · 2024 · International Journal of Nanomedicine
  5. Properties and feasibility of using cancer stem cells in clinical cancer treatment
    Gao Xiaomei, Zhang Rui, Dong Qiong-Zhu, Lun–Xiu Qin · 2016 · Cancer Biology and Medicine
  6. Immune Responses against Disseminated Tumor Cells
    Ling Peng, Yongchang Zhang, Zibing Wang · 2021 · Cancers
  7. Premetastasis
    Yoshiro Maru · 2019 · Cold Spring Harbor Perspectives in Medicine
  8. Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)
    Shigeru Imoto, Kun Wang, Xiwen Bi, Guangyu Liu, Young‐Hyuck Im, Seock‐Ah Im, Sung Hoon Sim, Takayuki Ueno, Manabu Futamura, Masakazu Toi et al. · 2023 · Breast Cancer
  9. A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
    David R. Wise, Russell Kent Pachynski, Samuel Ray Denmeade, Rahul Raj Aggarwal, Jiehui Deng, Victor Adorno Febles, Arjun Vasant Balar, Minas Platon Economides, Cynthia A. Loomis, Shanmugapriya Selvaraj et al. · 2024 · Prostate Cancer and Prostatic Diseases
  10. The emerging role and mechanism of HMGA2 in breast cancer
    Qing Ma, Sisi Ye, Hong Liu, Yu Zhao, Wei Zhang · 2024 · Journal of Cancer Research and Clinical Oncology
  11. Cancer stem cells: Masters of all traits
    Lionel Yi Wen Leck, Yomna S. Abd El-Aziz, Kelly J. McKelvey, Kyung Chan Park, Sumit Sahni, Darius J.R. Lane, Jan Skoda, Patric J. Jansson · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  12. Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse
    Diana Drago Garcia, Suvendu Giri, Rishita Chatterjee, Arturo Simoni Nieves, Maha Abedrabbo, Alessandro Genna, Mary Luz Uribe, Moshit Lindzen, Arunachalam Sekar, Nitin Gupta et al. · 2025 · Science Signaling
  13. Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma
    Wei Li, Lin Xu, Jun Shu Han, Kefei Yuan, Hong Mei Wu · 2019 · Frontiers in Oncology
  14. Cancer Stem Cells and Stem Cell Tumors in Drosophila
    Shree Ram Singh, Poonam Aggarwal, Xianyu Steven Hou · 2019 · Advances in experimental medicine and biology
  15. Harder, better, faster, stronger: biochemistry and biophysics in the immunosurveillance concert
    María Tello‐Lafoz, Miguel de Jesus, Morgan Huse · 2021 · Trends in Immunology
  16. ABL kinases regulate translation in HER2+ cells through Y-box-binding protein 1 to facilitate colonization of the brain
    Courtney McKernan, Aaditya Khatri, Molly M. Hannigan, Jessica R. Child, Qiang Chen, Benjamin Mayro, David J. Snyder, Christopher V. Nicchitta, Ann Marie Pendergast · 2022 · Cell Reports
  17. Epigenetic Regulation of Cancer Dormancy as a Plasticity Mechanism for Metastasis Initiation
    María Soledad Sosa, Emily Bernstein, Julio A. Aguirre‐Ghiso · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
  18. Chemotherapy-induced immunological breast cancer dormancy: a new function for old drugs?
    Sanam Peyvandi, Qiang Lan, Girieca Lorusso, Curzio R��egg · 2019 · Journal of Cancer Metastasis and Treatment
  19. Direct Tumor Irradiation Potentiates Adoptive NK Cell Targeting Against Parental and Stemlike Cancer in Human Liver Cancer Models
    Tung Nguyen Thanh Uong, Meesun Yoon, Ik‐Joo Chung, Taek‐Keun Nam, Sung‐Ja Ahn, Jae‐Uk Jeong, Ju‐Young Song, Yong-Hyub Kim, Huy Phuoc Quang Nguyen, Duck Cho et al. · 2023 · International Journal of Radiation Oncology*Biology*Physics
  20. How much do we know about the metastatic process?
    Carolina Rodríguez-Tirado, María Soledad Sosa · 2024 · Clinical & Experimental Metastasis
  21. A Live Tracker of Dormant Disseminated Tumor Cells
    Francisco Landum, Ana Luísa Correia · 2024 · Methods in molecular biology
  22. Tracing Quiescent Cancer Cells In Vivo
    Moon Jong Kim · 2024 · Cancers
  23. A Site-Specific MiniAp4–Trastuzumab Conjugate Prevents Brain Metastasis
    Mariam Masmudi‐Martín, Benjamí Oller‐Salvia, María Perea, Meritxell Teixidò, Manuel Valiente, Ernest Giralt, Macarena Sánchez‐Navarro · 2025 · Molecular Pharmaceutics
  24. A glucocorticoid–FAS axis controls immune evasion during metastatic seeding
    Monica Cassandras, Xavier Sanchez, Lauren Hsu, yu huang, Adam J. Getzler, Debolina Ganguly, Pilar Baldominos, Ia Codinachs, Jeffrey Chuong, Elizabeth E. Martin et al. · 2026 · Nature
  25. Dishevelled: An emerging therapeutic oncogene in human cancers.
    S. Alshahrani, N. Rakhimov, Arti Rana, H. Alsaab, A. Hjazi, Mohaned Adile, M. Abosaooda, Adeeb Abdulally Abdulhussien alazbjee, Ali H. Alsalamy, Reza Mahmoudi · 2023 · Pathology, Research and Practice
  26. Cell-mediated barriers in cancer immunosurveillance
    Jafar Rezaie, Leila Chodari, Shadi Mohammadpour-Asl, Abbas Jafari, Zahra Niknam · 2024 · Life Sciences
  27. Mouse Models to Study Natural Killer Cell-Mediated Immunosurveillance and Metastatic Latency
    Vidhya R. Nair, Srinivas Malladi · 2018 · Methods in molecular biology
  28. The Prognostic and Predictive Value of SOX2+ Cell Densities in Patients Treated for Colorectal Cancer
    Timothy J. Miller, Melanie J. McCoy, Tracey F. Lee‐Pullen, Chidozie C. Anyaegbu, Christine T. Hemmings, Max Kishor Bulsara, Cameron F E Platell · 2020 · Cancers
  29. SEC14L3 plays a tumor-suppressive role in breast cancer through a Wnt/β-catenin-related way.
    Qing-Luan Zhu, N. Wan, Hongwu Deng, Ling-Ling Lu, Yi Zhang, Xiao He, Hao Liu, Ying He · 2022 · Experimental Cell Research
  30. Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer
    Xiaojun Zhang, Yilan Huang, Qian Li, Yiqing Zhong, Yuanzhou Zhang, Jingying Hu, Rui Liu, Xiaoying Luo · 2023 · Frontiers in Immunology
  31. Quiescence-like Metabolism to Push Cancer Out of the Race
    Verónica Torrano, Arkaitz Carracedo · 2017 · Cell Metabolism
  32. Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells
    Jodi Wong, Stephen Yiu Chuen Choi, Rongrong Liu, Eddie Xu, James Killam, Peter W. Gout, Yuzhuo Z. Wang · 2019 · Frontiers in Cellular and Infection Microbiology
  33. Bone Metastasis Phenotype and Growth Undergo Regulation by Micro-Environment Stimuli: Efficacy of Early Therapy with HGF or TGFβ1-Type I Receptor Blockade
    Paola Bendinelli, Paola Maroni, Valentina Dall’Olio, Emanuela Matteucci, Maria Alfonsina Desiderio · 2019 · International Journal of Molecular Sciences
  34. Targeting phenotypic plasticity prevents metastasis and the development of chemotherapy-resistant disease
    Beatriz P. San Juan, Soroor Hediyeh-zadeh, Laura Rangel, Heloisa Helena Milioli, Vanina Rodríguez, Abigail Bunkum, Felix V Kohane, Carley A. Purcell, Dharmesh Dinesh Bhuva, Anie Kurumlian et al. · 2022 · medRxiv
  35. Microenvironmental Regulation of Dormancy in Breast Cancer Metastasis: “An Ally that Changes Allegiances”
    Evrim Ceren Kabak, Sok Lin Foo, Maria Rafaeva, Iván Martín, Mohamed Bentires‐Alj · 2025 · Advances in experimental medicine and biology
  36. SMYD4 promotes MYH9 ubiquitination through lysine monomethylation modification to inhibit breast cancer progression
    Jin-Shuo Yang, Jun-Ming Cao, Rui Sun, Xue-Jie Zhou, Zhaohui Chen, Bowen Liu, Xiaofeng Liu, Yue Yu, Xin Wang · 2025 · Breast Cancer Research
  37. Targeting Wnt-driven metabolic adaptations in cancer: integrating glycolysis, glutaminolysis, IDO1-mediated immune evasion, and therapeutic delivery strategies
    Eric Flores-Hernández, Grace Binder, Kuo‐Ching Mei, Nydia Tejeda‐Muñoz · 2025 · Frontiers in Cell and Developmental Biology
  38. Role of Cancer Stem Cells in Drug Resistance
    Kaneez Fatima, Shariqa Jan, Fayaz Ahmad Malik, Sameer Ullah Khan · 2024 · Springer eBooks
  39. Challenges and opportunities for cancer stem cell‐targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell‐dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes
    Abdullah Alqarni, Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Harpreet Kaur, Irwanjot Kaur, Carlos Rodriguez‐Benites, Mahamedha Deorari, Enas R. Alwaily, Ahmed Muzahem Al‐Ani, Ahmed Huseen Redhee · 2024 · Journal of Biochemical and Molecular Toxicology
  40. Cancer treatments as paradoxical catalysts of tumor awakening in the lung
    Émmanuelle Nicolas, Beata Kośmider, Edna Cukierman, Hossein Borghaei, Erica A. Golemis, Lucia Borriello · 2024 · Cancer and Metastasis Reviews
  41. The impact of the tumor microenvironment on the survival of penile cancer patients
    Stefan Lohse, Jan Niklas Mink, Lea Eckhart, Muriel Charlotte Hans, Leuart Jusufi, Anabel Zwick, Tobias Mohr, Isabelle Ariane Bley, Oybek Khalmurzaev, Vsevolod Borisovich Matveev et al. · 2024 · Scientific Reports
  42. Recent Advances in β-catenin/BCL9 protein–protein Interaction Inhibitors
    Hao Zhang, Ya Bao, Chenglong Liu, Jianqi Li, Di Zhu, Qingwei Zhang · 2021 · Future Medicinal Chemistry
  43. Controlling Wnt Signaling Specificity and Implications for Targeting WNTs Pharmacologically
    Pooja R. Sonavane, Karl Willert · 2021 · Handbook of experimental pharmacology
  44. Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells
    Ethan P. Metz, Phillip J. Wilder, Tessa M. Popay, Jing Wang, Qi Liu, Achyuth Kalluchi, M. Jordan Rowley, William P. Tansey, Angie Rizzino · 2022 · Cancers
  45. GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
    Khoa Nguyen, Emily C. McConnell, Orielle Edwards, Bridgette M. Collins‐Burow, Matthew E. Burow · 2022 · Cancer Drug Resistance
  46. Immune Privileges as a Result of Mutual Regulation of Immune and Stem Systems
    Dmitriy Vladimirovich Karpenko · 2023 · Biochemistry (Moscow)
  47. Surviving the Storm: The Role of Poly‐ and Depolyploidization in Tissues and Tumors
    Yucui Zhao, Sijia He, Minghui Zhao, Qian Huang · 2024 · Advanced Science
  48. Tracing bone marrow-derived microglia in brain metastatic tumors
    Wei Du, Paula D. Bos · 2020 · Methods in enzymology on CD-ROM/Methods in enzymology
  49. Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer
    Anna J. Wiecek, Stephen J. Cutty, Daniel Kornai, Mario Parreno-Centeno, Lucie E. Gourmet, Guidantonio Malagoli Tagliazucchi, Daniel H. Jacobson, Ping Zhang, Lingyun Xiong, Gareth L. Bond et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer
    Shiqin Jiang, Yichun Tang, Feng Ma, Yuchun Niu, Lei Sun · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  51. Sustained Oncogenic Signaling in the Cytostatic State Enables Targeting of Nonproliferating Persistent Cancer Cells
    Lisa M. Kim, Paul Y. Kim, Yemarshet Kelemework Gebreyohannes, Cheuk T. Leung · 2022 · Cancer Research
  52. The covert symphony: cellular and molecular accomplices in breast cancer metastasis
    Hongjiang Si, Madelyn Esquivel, Erika Mendoza Mendoza, Kevin P. Roarty · 2023 · Frontiers in Cell and Developmental Biology
  53. Organotypic Brain Cultures for Metastasis Research
    Lucía Zhu, Manuel Valiente · 2020 · Neuromethods
  54. Developmental Insights into Lung Cancer
    Tushar Desai · 2021 · Annual Review of Cancer Biology
  55. The Tumour Microenvironment and Circulating Tumour Cells: A Partnership Driving Metastasis and Glycan-Based Opportunities for Cancer Control
    Andreia Peixoto, Sofia Cotton, Lúcio Lara Santos, José Alexandre Ferreira · 2021 · Advances in experimental medicine and biology
  56. The genomic regulation of metastatic dormancy
    Irwin H. Gelman · 2023 · Cancer and Metastasis Reviews
  57. The link between wound healing and escape from tumor dormancy
    Hanna Dillekås, Oddbjørn Straume · 2018 · Surgical Oncology
  58. Tumor Dormancy and Relapse Regulated by the Extracellular Matrix
    Hyuna Kim, Rebecca E. Huber, Rita Das Mahapatra, Ning-Hsuan Tseng, Shelly R. Peyton · 2022 · Springer eBooks
  59. The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
    Tsung-Cheng Lin, Ying‐Chih Liao, Wen‐Tsan Chang, Cheng-Han Yang, Li-Hsin Cheng, Megan Cheng, Hung-Chi Cheng · 2018 · Journal of Visualized Experiments
  60. Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance
    Myron John Tong, Carmem Ferguson Theodoro, Rebecca Salvo · 2018 · Journal of Digestive Diseases
  61. Current landscape and challenges ahead of immuno-molecular mechanism and immunotherapy strategy of brain metastases
    Hanfei Guo, Bin Wang, Wenqian Li, Naifei Chen, Jiuwei Cui · 2023 · Holistic Integrative Oncology
  62. PDGFR-targeted nanovesicles for restraining breast cancer hepatic metastasis via hepatic stellate cell regression and NK cell activation
    Mengjie Kong, Yan Peng, Yujie Miao, Liyan Qiu · 2024 · Materials Today
  63. Molecular mechanisms altering cell identity in cancer
    Alessio Zippo, Sven Beyes · 2025 · Oncogene
  64. Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin–driven Tumor Progression and Immune Escape in Prostate Cancer
    Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, Michael Y. Xu, Marc Carceles‐Cordon, Adam Ertel, S. Aidan Quinn, Daniel Peter Petrylak, Jacob J. Orme, Scott M. Dehm et al. · 2025 · Cancer Discovery
  65. Driver gene-specific prevalence and incidence of brain metastases in non-small cell lung cancer: a meta-analysis encompassing all disease stages
    Yu Zhang, Yuxin Wen, Peiyang Fan, Fangfang Li, Muye Li, Zhiyuan Wang, Xiaofang Wang, Zichen Mao, Yanxun Li, Yuchen Yao et al. · 2025 · Discover Oncology
  66. Advanced biomedical applications of cerium oxide nanoparticles: Intrinsic property–driven therapeutic multifunctionality, drug delivery system design and toxicological assessment
    Nian Liu, Xiaojiang Hou, Xiaoning Wang, Wenting Wang · 2025 · Materials Today Chemistry
  67. Sleepyhead, deadly awakening: the dynamics of metastatic organotropism, tumor dormancy and therapeutic implications
    Soumyajit Sarkar, P.K. Suresh · 2025 · Frontiers in Oncology
  68. PM 10 Impairs CD56 dim NK Cell Cytotoxicity via FNBP1 Suppression to Exacerbate Rheumatoid Arthritis: Insights from Multimodal Multi‐Omics
    Runhan Zhao, Qinyang Zhang, Yu Jiang, Dagang Tang, Xiao Qu, Jun Zhang, Yi Chen, Weixia Duan, T Li, Yanran Huang et al. · 2026 · Advanced Science
  69. The sleeping threat: targeting cancer dormancy to transform metastasis therapy
    Julio A. Aguirre‐Ghiso, Jose Javier Bravo‐Cordero, Wenjun Guo, Gregoire S. Lauvau, María Soledad Sosa · 2026 · Nature reviews. Cancer
  70. SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions
    Briana D. Ormsbee, Daisy V. Gonzalez, Gregory S. Yochum, Donald W. Coulter, Angie Rizzino · 2024 · Journal of Biological Chemistry
  71. Strong Immune Privileges of MSC and Other Nes-GFP + Progenitors in Bone Marrow of Transgenic Mice
    Dmitriy Vladimirovich Karpenko, Капранов Николай Михайлович, Alexey Bigildeev · 2025 · Immune Network
  72. Type 2 Dendritic Cells Orchestrate a Local Immune Circuit to Confer Antimetastatic Immunity
    Orr-El Weizman, Sophia Luyten, Irina Krykbaeva, Eric Song, Tianyang Mao, Marcus Bosenberg, Akiko Iwasaki · 2023 · The Journal of Immunology
  73. Effector and cytolytic function of natural killer cells in anticancer immunity
    Surojit Karmakar, Amrita Mishra, Pradipta Pal, Girdhari Lal · 2023 · Journal of Leukocyte Biology
  74. Immune Microenvironment in Breast Cancer Metastasis
    Bin‐Zhi Qian, Ruoyu Ma · 2025 · Advances in experimental medicine and biology
  75. Discovery of Airway-Administered Ionophores for Mn2+ to Mitigate Lung Metastasis by Targeting Disseminated Tumor Cell
    Yuming Wang, Ni Fan, Rui Wang, Xue Li, Feng Zhao, Lin Miao, Xi Wang, Xiaohui Yan, Zhang Zhang, Xuanjun Wu et al. · 2025 · ACS Nano
  76. Targeted Therapies in the Most Common Advanced Solid Tumors, Drug Resistance, and Counteracting Progressive Micrometastatic Disease: The Next Frontier of Research
    Andrea Nicolini, Paola Ferrari, Roberto Silvestri, Dario A. Bini · 2025 · MedComm
  77. Mouse genomic screen reveals novel host regulator of metastasis
    Toni Celià-Terrassa, Yibin Kang · 2017 · Genome biology
  78. The number of prior lines of systemic therapy as a prognostic factor for patients with brain metastases treated with stereotactic radiosurgery: Results of a large single institution retrospective analysis
    C.M. Lanier, E. McTyre, Michael C. LeCompte, Christina Kehl Cramer, Ryan T. Hughes, Kounosuke Watabe, Hui‐Wen Lo, Stacey S. O’Neill, Michael T. Munley, Adrian W. Laxton et al. · 2017 · Clinical Neurology and Neurosurgery
  79. Anti-angiogenic Therapy-Mediated Endothelial Damage: A Driver of Breast Cancer Recurrence?
    Laura Pisarsky, Cyrus Michael Ghajar · 2018 · Advances in experimental medicine and biology
  80. Tumor cell-organized fibronectin is required to maintain a dormant breast cancer population
    Lauren E. Barney, Christopher L. Hall, Alyssa D. Schwartz, Akia N. Parks, Christopher Sparages, Sualyneth Galarza, Manu O. Platt, Arthur M. Mercurio, Shelly R. Peyton · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Targeting Interferon-Driven Inflammatory Memory Prevents Epigenetic Evolution of Cancer Immunotherapy Resistance
    Jingya Qiu, Darwin Ye, Xinyi E. Chen, Nathan J Dangle, Benjamin Yoshor, Thomas Zhang, Yue Shao, Vamshidhar C. Nallamala, Shangshang Wang, Diqiu Ren et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Macrophage regulation of tumor cell dormancy and the dormant niche: an overview in solid tumors
    Hongxing Zhang, Yiyue Ding, Lihui Gu, Ai Guo, Wanli Duan, Xuejie Wang, Baogang Zhang · 2025 · Cancer and Metastasis Reviews
  83. Platelets and platelet-derived extracellular vesicles: their role in lung cancer dissemination and premetastatic niche formation
    Camilla Locatelli, Nicole Ferrario, Orazio Fortunato, Patrizia Ghidotti, Rossella Crescitelli · 2025 · Frontiers in Immunology
  84. Targeting DKK1 to Remodel the Tumor Microenvironment and Enhance Immune Checkpoint Blockade Therapy
    Tao Shi, Jia Wei · 2024 · Journal of Clinical Oncology
  85. DKK1 and Its Receptors in Esophageal Adenocarcinoma: A Promising Molecular Target
    Markos Despotidis, Orestis Lyros, Tatiana S. Driva, Panagiotis Sarantis, Emmanouil Ioannis Kapetanakis, Adam Mylonakis, Andreas Mamilos, Stratigoula Sakellariou, Dimitriοs Schizas · 2025 · Diagnostics
  86. Prognostic value of Dickkopf-1 and ß-catenin expression according to the antitumor immunity of CD8-positive tumor-infiltrating lymphocytes in biliary tract cancer
    Seoree Kim, Hye Sung Won, Ji Hyun Yang, Der Sheng Sun, Kwangil Yim, Min Eui Hong, Soon Auck Hong, Jung‐Sook Yoon, Sang Hoon Chun, Kee‐Hwan Kim et al. · 2022 · Scientific Reports
  87. CXCL12–CXCR4 Axis in Cancer Metastasis
    Manzoor Ahmad Mir, Ab Qayoom Naik, Mohd Zahoor ul haq Shah, Tabassum Zafar · 2023 · Springer eBooks
  88. Leveraging Xenobiotic-Responsive Cancer Stemness in Cell Line-Based Tumoroids for Evaluating Chemoresistance: A Proof-of-Concept Study on Environmental Susceptibility
    Ki Hyung Kim, Seung Joon Lee, Juil Kim, Yuseok Moon · 2024 · International Journal of Molecular Sciences
  89. Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
    Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie J. Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark O. DeNichilo et al. · 2025 · Molecular Oncology
  90. CK1δ: an exploitable vulnerability in breast cancer
    Laura H. Rosenberg, John L. Cleveland, William R. Roush, Derek R. Duckett · 2016 · Annals of Translational Medicine
  91. Tumor cell dormancy: Molecular mechanisms, and pharmacological approaches to target dormant cells for countering tumor
    Muhammad Usama Saeed, Nazim Hussain, Iqra Zulfiqar, Ali Raza, Mohsin Ahmad Ghauri, Muhammad Bilal · 2022 · Journal of Drug Delivery Science and Technology
  92. Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression via Activating the Wnt/β-Catenin Signaling Pathway
    Jianchao He, Yuhui Bu, Xiaolong Li, Xiaojun Zhang, Li Ma · 2022 · Biological and Pharmaceutical Bulletin
  93. Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
    Albert Grinshpun, Douglas Russo, Wen Ma, Ana Verma, Francisco Hermida‐Prado, Shira Sherman, Giorgio Gaglia, Sheheryar Kairas Kabraji, Gregory John Kirkner, Melissa E. Hughes et al. · 2024 · npj Breast Cancer
  94. A state of stochastic cancer stemness through the CDK1-SOX2 axis
    Dinoop Ravindran Menon, Mayumi Fujita · 2019 · Oncotarget
  95. An Emerging Model for Cancer Development from a Tumor Microenvironment Perspective in Mice and Humans
    Ryuji Yamaguchi, Guy A Perkins · 2020 · Advances in experimental medicine and biology
  96. Breast Cancer Bone Metastasis
    Marie‐Therese Haider, Jennifer Zarrer, Hanna Taipaleenmäki · 2019 · Elsevier eBooks
  97. Editorial: Revisiting seed and soil: A new approach to target hibernating dormant tumor cells
    Angélica Santiago-Gómez, Dalit Barkan, Ann F. Chambers · 2023 · Frontiers in Oncology
  98. Balancing tumour proliferation and sustained cell cycle arrest through proteostasis remodelling drives immune niche compartmentalisation in breast cancer
    Cenk Celik, Eloise Withnell, Pan Shi, T. Ming Chu, John P. Labbadia, Maria Secrier · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Vascular‐Associated Mononuclear Phagocytes: First‐Line Soldiers Ambushing Metastasis
    Han‐ying Huang, Xin-Nan Zheng, Lin Hai Tian · 2024 · BioEssays
  100. SOX9: an important factor in regulating breast cancer
    Yaru Wang, Juhang Chu, Luyao Huang, Mingping Qian · 2025 · European journal of medical research